Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

7B.01: FINAL ANALYSIS ON ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN TREATMENT RESISTANT HYPERTENSION (TRH) UNDERGOING RENAL DENERVATION (RDN).

Schmieder RE, Ott C, Veelken R, Schmid A, Uder M, Toennes SW.

J Hypertens. 2015 Jun;33 Suppl 1:e92. doi: 10.1097/01.hjh.0000467598.27100.ca.

PMID:
26102969
2.

Central pulse pressure predicts BP reduction after renal denervation in patients with treatment-resistant hypertension.

Ott C, Schmid A, Toennes SW, Ditting T, Veelken R, Uder M, Schmieder RE.

EuroIntervention. 2015 May 19;11(1):110-6. doi: 10.4244/EIJV11I1A19.

3.

Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.

Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, Veelken R, Ukena C, Uder M, Böhm M, Schmieder RE.

J Hypertens. 2015 Jun;33(6):1261-6. doi: 10.1097/HJH.0000000000000556.

PMID:
25923731
4.

Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients.

Ott C, Harazny JM, Schmid A, Ditting T, Veelken R, Bladowski M, Michelson G, Uder M, Schmieder RE.

Clin Res Cardiol. 2015 Apr 28. [Epub ahead of print]

PMID:
25916737
5.

[Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology].

Vonend O, Böhm M, Eckert S, Hausberg M, Rittger H, Rump LC, Schmieder R, Schulte KL, Schunkert H, Uder M, Veelken R, Vorwerk D, Weil J, Wenzel U, Mahfoud F.

Dtsch Med Wochenschr. 2015 Mar;140(5):363. doi: 10.1055/s-0041-100835. Epub 2015 Mar 3. German.

PMID:
25734680
6.

Circadian rhythm and day to day variability of serum potassium concentration: a pilot study.

Schmidt ST, Ditting T, Deutsch B, Schutte R, Friedrich S, Kistner I, Ott C, Raff U, Veelken R, Schmieder RE.

J Nephrol. 2015 Apr;28(2):165-72. doi: 10.1007/s40620-014-0115-7. Epub 2014 Jul 3.

PMID:
24990164
7.

Renal denervation--implications for chronic kidney disease.

Veelken R, Schmieder RE.

Nat Rev Nephrol. 2014 Jun;10(6):305-13. doi: 10.1038/nrneph.2014.59. Epub 2014 Apr 15. Review.

PMID:
24733118
8.

Improvement of albuminuria after renal denervation.

Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE.

Int J Cardiol. 2014 May 1;173(2):311-5. doi: 10.1016/j.ijcard.2014.03.017. Epub 2014 Mar 15.

PMID:
24681017
9.

Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of endoplasmic reticulum stress.

Hartner A, Cordasic N, Klanke B, Menendez-Castro C, Veelken R, Schmieder RE, Hilgers KF.

Biochim Biophys Acta. 2014 Apr;1842(4):558-65. doi: 10.1016/j.bbadis.2014.01.001. Epub 2014 Jan 10.

10.

Renal sympathetic denervation as antihypertensive therapy--a reappraisal of first results.

Veelken R, Mann JF.

Nephrol Dial Transplant. 2013 Nov;28(11):2698-701. doi: 10.1093/ndt/gft017. Epub 2013 Aug 14. Review.

PMID:
23945992
11.

Renal denervation in moderate treatment-resistant hypertension.

Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.

J Am Coll Cardiol. 2013 Nov 12;62(20):1880-6. doi: 10.1016/j.jacc.2013.06.023. Epub 2013 Jul 10.

12.

Does renal artery supply indicate treatment success of renal denervation?

Schmid A, Ditting T, Sobotka PA, Veelken R, Schmieder RE, Uder M, Ott C.

Cardiovasc Intervent Radiol. 2013 Aug;36(4):987-91. doi: 10.1007/s00270-013-0652-9. Epub 2013 Jun 15.

PMID:
23771326
13.

Vascular and renal hemodynamic changes after renal denervation.

Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1195-201. doi: 10.2215/CJN.08500812. Epub 2013 Apr 4.

14.

Sensory renal innervation: a kidney-specific firing activity due to a unique expression pattern of voltage-gated sodium channels?

Freisinger W, Schatz J, Ditting T, Lampert A, Heinlein S, Lale N, Schmieder R, Veelken R.

Am J Physiol Renal Physiol. 2013 Mar 1;304(5):F491-7. doi: 10.1152/ajprenal.00011.2012. Epub 2013 Jan 2.

15.

Renal denervation in a hypertensive patient with end-stage renal disease and small arteries: a direction for future research.

Ott C, Schmid A, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE.

J Clin Hypertens (Greenwich). 2012 Nov;14(11):799-801. doi: 10.1111/jch.12017. Epub 2012 Oct 3.

PMID:
23126353
16.

An experimental procedure paid for by the general public.

Mann J, Hilgers K, Veelken R, Luft F.

Dtsch Arztebl Int. 2012 Apr;109(17):311-2; author reply 313-4. doi: 10.3238/arztebl.2012.0311c. Epub 2012 Apr 27. No abstract available.

17.

Tonic postganglionic sympathetic inhibition induced by afferent renal nerves?

Ditting T, Freisinger W, Siegel K, Fiedler C, Small L, Neuhuber W, Heinlein S, Reeh PW, Schmieder RE, Veelken R.

Hypertension. 2012 Feb;59(2):467-76. doi: 10.1161/HYPERTENSIONAHA.111.185538. Epub 2012 Jan 3.

18.

Reversibility of the effects of aliskiren in the renal versus systemic circulation.

Schneider MP, Janka R, Ziegler T, Raff U, Ritt M, Ott C, Veelken R, Uder M, Schmieder RE.

Clin J Am Soc Nephrol. 2012 Feb;7(2):258-64. doi: 10.2215/CJN.05870611. Epub 2011 Dec 15.

19.

Norepinephrine reduces ω-conotoxin-sensitive Ca2+ currents in renal afferent neurons in rats.

Ditting T, Linz P, Freisinger W, Heinlein S, Reeh PW, Fiedler C, Siegel K, Scrogin KE, Neuhuber W, Veelken R.

Am J Physiol Renal Physiol. 2012 Feb 1;302(3):F350-7. doi: 10.1152/ajprenal.00681.2010. Epub 2011 Nov 2.

20.

Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.

Knier B, Cordasic N, Klanke B, Heusinger-Ribeiro J, Daniel C, Veelken R, Hartner A, Hilgers KF.

J Hypertens. 2011 Aug;29(8):1602-12. doi: 10.1097/HJH.0b013e32834840e8.

PMID:
21610512
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk